Uncategorized

How AI can positively change the clinical trials industry

Breaking the BioPharma paradox of cutting-edge science and lagging digital transformation

How pharma can learn and benefit from disruptive entrepreneurs

Levelling up – the NHS’ healthcare equity campaign and why pharma should back it

Creating an inclusive vibe must be a pharma vision we all share

Superpower or Clark Kent – what is the future for UK life sciences?

How can biopharma companies embed patient-centricity and boost the patient voice?

A spectacular ceremony paid homage to the stars while paving the way for an exciting future. Editor John Pinching reports from London

Editor John Pinching reviews Michael J. Fox’s remarkable new film about the reality of living with Parkinson’s disease

Cambridge is the jewel in pharma’s crown but it is due a polish

The key to realising product and process visibility across the life sciences

Three years on, how did the pandemic transform pharmacovigilance?

The EU Commission’s proposals to revise pharmaceutical legislation is a step forward but there is more work to do

Oncology – what does it show us about the wider NHS in the years ahead?

Why commercial sponsors should continue to choose the UK when delivering clinical research